421 related articles for article (PubMed ID: 25623282)
1. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases.
Lim HC; Couchman JR
Biochim Biophys Acta; 2014 Aug; 1840(8):2482-90. PubMed ID: 24447566
[TBL] [Abstract][Full Text] [Related]
3. Podocytes require the engagement of cell surface heparan sulfate proteoglycans for adhesion to extracellular matrices.
Chen S; Wassenhove-McCarthy D; Yamaguchi Y; Holzman L; van Kuppevelt TH; Orr AW; Funk S; Woods A; McCarthy K
Kidney Int; 2010 Dec; 78(11):1088-99. PubMed ID: 20463653
[TBL] [Abstract][Full Text] [Related]
4. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
5. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
6. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells.
Burbach BJ; Ji Y; Rapraeger AC
Exp Cell Res; 2004 Oct; 300(1):234-47. PubMed ID: 15383330
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas.
Mundhenke C; Meyer K; Drew S; Friedl A
Am J Pathol; 2002 Jan; 160(1):185-94. PubMed ID: 11786412
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions.
Liu W; Litwack ED; Stanley MJ; Langford JK; Lander AD; Sanderson RD
J Biol Chem; 1998 Aug; 273(35):22825-32. PubMed ID: 9712917
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
Winkler S; Stahl RC; Carey DJ; Bansal R
J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
[TBL] [Abstract][Full Text] [Related]
12. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 and -4 differentially regulate oncogenic K-ras dependent cell invasion into collagen through α2β1 integrin and MT1-MMP.
Vuoriluoto K; Högnäs G; Meller P; Lehti K; Ivaska J
Matrix Biol; 2011 Apr; 30(3):207-17. PubMed ID: 21414405
[TBL] [Abstract][Full Text] [Related]
14. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
[TBL] [Abstract][Full Text] [Related]
16. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells.
Beauvais DM; Rapraeger AC
Exp Cell Res; 2003 Jun; 286(2):219-32. PubMed ID: 12749851
[TBL] [Abstract][Full Text] [Related]
18. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
[TBL] [Abstract][Full Text] [Related]
19. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
20. Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways.
Whiteford JR; Behrends V; Kirby H; Kusche-Gullberg M; Muramatsu T; Couchman JR
Exp Cell Res; 2007 Nov; 313(18):3902-13. PubMed ID: 17870067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
